EB病毒感染阳性鼻咽癌与调节性T细胞的相关性分析

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (40 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the correlation between nasopharyngeal carcinoma in Epstein-Barr（EB） virus positivity and regulatory T cells and to explore its reference value for the clinical diagnosis and prognosis of the disease.Methods 35 patients with EB virus positivity of nasopharyngeal carcinoma admitted in our hospital from April 2015 to February 2017 and 40 healthy participants during the same period undergoing physical examinations in our hospital were selected as research objects.They were divided into observation group and control group respectively.Fasting venous blood was collected from the two groups to detect the level of regulatory T cells.The difference between the detection results of nasopharyngeal carcinoma patients with EB virus positivity and healthy participants was compared,and the change of regulatory T cell levels before and after treatment were observed.Results The levels of CD4+CD25+Foxp3+Treg and CD4+CD25+Foxp3+Treg/CD4+T of regulatory T cells in the observation group were significantly higher than those in the control group with significant differences between the two groups(P＜0.05).After treatment,the levels of CD4+CD25+Foxp3+Treg and CD4+CD25+Foxp3+Treg/CD4+of regulatory T cells in the observation group were lower than that in the before treatment,with statistical differences(P＜0.05).Conclusion The occurrence and development of nasopharyngeal carcinoma in EB virus positivity may cause the change of regulatory T cell levels in patients.By detecting the level of regulatory T cells,it to a certain extent can reflect the patient′s condition and the recovery after treatment,which has an important reference value for the clinical diagnosis and prognosis of the disease.

Key words： Nasopharyngeal carcinoma in epstein-barr virus positivity Regulatory T cells Correlation

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHONG Qi-long
	FU Guo-wu
	LIANG Xiao-ming

Cite this article:

ZHONG Qi-long,FU Guo-wu,LIANG Xiao-ming. Correlation analysis of nasopharyngeal carcinoma in Epstein-Barr virus positivity and regulatory T cells[J]. 中国当代医药, 2018, 25(11): 78-80.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I11/78

[1]	Bautista J，Bella A，Chaudhari A，et al.Advanced chronickidney disease in non-valvular atrial fibrillation：extending the utility of R2CHADS2 to patients with advanced renalfailure[J].Clin Kidney J，2015，8（2）：226-231.
[2]	汪铁军，谢中华，郑元秀，等.初诊鼻咽癌患者外周血CD4+CD25+Foxp3+调节性T细胞的变化及与TGF-β1的相关性[J].放射免疫学杂志，2013，26（4）：474-476.
[3]	林灿峰，李东升，辛淑波，等.鼻咽癌497例治疗失败分析[J].广东医学，2014，35（4）：528-529.
[4]	Liu L，Yao J，Ding Q，et al.Analysis of peripheral blood CD4+CD25high regulatory T cells in patients with nasopharyngeal carcinoma[J].Clin J Otolaryngol，2015，29（20）：929-931.
[5]	梁新强，刘海洲，唐亚梅，等.鼻咽癌患者治疗前后外周血CD4+CD25+调节性T细胞和 CD19+CD35+细胞的变化[J].广西医学，2015，37（7）：910-912.
[6]	Tian YM，Tian YH，Zeng L，et al.Prognostic modelfor survival of local recurrent nasopharyngeal carcinoma with intensitymodulated radiotherapy[J].Br J Cancer，2014，110（2）：297-303.
[7]	吴伟，刘联斌，周茂华.放化疗对鼻咽癌患者淋巴细胞亚群影响的观察[J].中华肿瘤防治杂志，2013，20（2）：129-132.
[8]	Chambless LB，Kistka HM，Parker SL，et al.The rel-ative value of postoperative versus preoperative KarnofskyPerformance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme[J].J Neurooncol，2015，121（2）：359-364.
[9]	福军亮，王福生.CD4+杀伤性 T细胞在病毒感染和肿瘤性疾病中的研究进展[J].细胞与分子免疫学杂志，2012，28（1）：102-104.
[10]	郭美姿，陈晓琳，尹震宇.Th17/Treg失衡在消化道肿瘤中的研究进展[J].国际消化病杂志，2013，33（5）：341-344.
[11]	蔡曼波，曾益新，邵建永，等.肿瘤微环境中Treg细胞和Th17细胞对鼻咽癌进展和预后的影响[J].湖南师范大学学报（医学版），2016，13（3）：1-4.
[12]	Wang T，Xie Z，Zheng Y，et al.Changes of CD4+CD25+Foxp3+regulatory T cells in peripheral blood of patients with newly diagnosed nasopharyngeal carcinoma and their correlation with TGF-beta 1[J].J Radioimmunol，2013，26（4）：474-476.
[13]	黄继红，昂杰，牟忠林，等.Treg细胞和Th17细胞在鼻咽癌中相关性的研究[J].海南医学院学报，2013，19（10）：1375-1377.
[14]	叶妮，张光波，高楠，等.Th17与Foxp3+Treg在胃癌患者外周血中的表达[J].世界华人消化杂志，2012，20（36）：3689-3694.
[15]	张增光，秦鸣放.肝癌患者外周血Treg、Th17百分比及IL-17 水平观察[J].山东医药，2015，4（15）：37-39.